Samuel Bengio

Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ.

Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France.

Ipsen Ltd. develops and markets medicinal products. The firm provides Decapepty, Disport, Hexvix, Increlex and Somatuline. The company is headquartered in Slough, the United Kingdom.

Biovector Therapeutics SA develops products for the prevention and treatment of infectious diseases and cancer. The private company is based in Labege, France. and has subsidiaries in France.

Part of Xiamen Comfort Science & Technology Group Co., Ltd., promed GmbH sells medical equipment for nail and skin care. The company is based in Farchant, Germany. The CEO of the German company is Andreas Schuster. promed was acquired by Medisana GmbH, part of Xiamen Comfort Science & Technology Group Co., Ltd. from October 27, 2016 on August 30, 2005 for $0.71 million.

Syngenta Biotechnology, Inc. provides genetics research and development services and is ultimately controlled by the Government of China. The company is based in Research Triangle Park, NC.

Rhenovia Pharma SAS provides pharmaceutical research services. It offers solutions in the field of Alzheimer's and other diseases of the nervous system. The firm’s product include Directorug discovery optimization service, first operational service and consulting service. The company was founded by Serge Bischoff, Michel Baudry, Michel Faupel, Jacques Baudry and Jan Kremers in May 2007 and is headquartered in Mulhouse, France.

Emosis SAS engages in research and experimental development on natural science and engineering. It addresses the unmet testing needs of patients presenting a broad range of conditions, such as cardiovascular and cerebrovascular diseases, cancer, pregnancy or surgical complications and complication of oral contraceptives, associated with bleeding and blood clotting disorders hemostasis and thrombosis in medical parlance. The company was founded by Aaron Tomer and Frederic Allemand in 2015 and is headquartered in Illikirch-Graffenstaden, France.